Immune tolerance: mechanisms and application in clinical transplantation (Q36909564)

17 August 2017

1 reference

title

Immune tolerance: mechanisms and application in clinical transplantation (English)

1 reference

17 August 2017

Sykes M

1

1 reference

PubMed ID

17697153

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Journal of Internal Medicine

17 August 2017

1 reference

17 August 2017

262

1 reference

17 August 2017

3

1 reference

17 August 2017

288-310

1 reference

Mixed chimerism as an approach for the induction of transplantation tolerance

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Peptides in positive and negative selection: a delicate balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

T-cell-receptor affinity and thymocyte positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

The fourth way? Harnessing aggressive tendencies in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Alloantigen persistence in induction and maintenance of transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Skin allograft maintenance in a new synchimeric model system of tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

T cell anergy and costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Tolerogenic dendritic cells: cytokine modulation comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Multiple levels of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Functional and molecular comparison of anergic and regulatory T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Infection breaks T-cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Regulatory T cells and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Regulatory T cells and mechanisms of immune system control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Tolerance, not immunity, crucially depends on IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Regulatory T cells in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Induction of transplantation tolerance via regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

What is the role of regulatory T cells in transplantation tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Regulatory T cells in transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Identification of regulatory T cells in tolerated allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Examination of the mechanisms responsible for tolerance induction after intrathymic inoculation of allogeneic bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Messenger RNA for FOXP3 in the urine of renal-allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Association of Foxp3 regulatory gene expression with graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Multiple pathways to allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+ cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Induced peripheral regulatory T cells: the family grows larger

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

The CD40 pathway in allograft rejection, acceptance, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Mast cells are essential intermediaries in regulatory T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Mixed chimerism and transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Outcomes of recipients of both bone marrow and solid organ transplants. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Graft-versus-leukemia reactions in allogeneic chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Self recognition in allogeneic radiation bone marrow chimeras. A radiation- resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Tolerance in mixed chimerism - a role for regulatory cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Chimerism and transplantation tolerance: cause and effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Induction of long-term graft tolerance and donor/recipient chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

NK cell tolerance in mixed allogeneic chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Efficacy of adhesive interactions in pig-to-human xenotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Specific tolerance across a discordant xenogeneic transplantation barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Transplantation of thymus tissue in complete DiGeorge syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Xenogeneic thymus transplantation in a pig-to-baboon model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Production of alpha 1,3-galactosyltransferase-deficient pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Autoimmune diabetes as a consequence of locally produced interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

TGF- in allogeneic stem cell transplantation: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01855.X

10.1111/J.1365-2796.2007.01855.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17697153